{"id":342549,"date":"2025-08-20T18:21:50","date_gmt":"2025-08-20T18:21:50","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-edwards-lifesciences-corporation\/"},"modified":"2025-08-20T18:21:50","modified_gmt":"2025-08-20T18:21:50","slug":"how-to-buy-edwards-lifesciences-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/","title":{"rendered":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342549","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Edwards Lifesciences Corporation (EW) hissesine yat\u0131r\u0131m yapmay\u0131 \u00f6\u011frenin; g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 piyasa f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci.","description_source":{"label":"Description","type":"textarea","formatted_value":"Edwards Lifesciences Corporation (EW) hissesine yat\u0131r\u0131m yapmay\u0131 \u00f6\u011frenin; g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 piyasa f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci."},"intro":"Ger\u00e7ekten kalpleri kurtaran bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Edwards Lifesciences Corporation (sembol: EW), yap\u0131sal kalp inovasyonunda k\u00fcresel liderdir ve kardiyovask\u00fcler bak\u0131m\u0131 d\u00f6n\u00fc\u015ft\u00fcren t\u0131bbi cihazlar \u00fcretmektedir. D\u00fcnya genelinde ya\u015flanan n\u00fcfuslar ve minimal invaziv tedavilere artan talep ile bu \u015firket, sa\u011fl\u0131k teknolojisi ve demografik trendlerin tam ortas\u0131nda yer almaktad\u0131r. EW'nin yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fczde neden g\u00fc\u00e7l\u00fc bir \u015fekilde yer alabilece\u011fini birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Ger\u00e7ekten kalpleri kurtaran bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Edwards Lifesciences Corporation (sembol: EW), yap\u0131sal kalp inovasyonunda k\u00fcresel liderdir ve kardiyovask\u00fcler bak\u0131m\u0131 d\u00f6n\u00fc\u015ft\u00fcren t\u0131bbi cihazlar \u00fcretmektedir. D\u00fcnya genelinde ya\u015flanan n\u00fcfuslar ve minimal invaziv tedavilere artan talep ile bu \u015firket, sa\u011fl\u0131k teknolojisi ve demografik trendlerin tam ortas\u0131nda yer almaktad\u0131r. EW'nin yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fczde neden g\u00fc\u00e7l\u00fc bir \u015fekilde yer alabilece\u011fini birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Edwards Lifesciences Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla Edwards Lifesciences Corporation (EW), NYSE'de <strong>78,93 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Bu, yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir an\u0131 temsil ediyor - hisse senedi, Temmuz 2025'te ula\u015f\u0131lan 52 haftal\u0131k en y\u00fcksek seviye olan 83,00 $'\u0131n sadece %5 alt\u0131nda i\u015flem g\u00f6r\u00fcyor ve g\u00fc\u00e7l\u00fc temellerini koruyor.<\/p> <p><strong>Takviminize Not Edin: 23 Ekim 2025<\/strong> - Edwards, piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketlerine neden olur. \u015eirket, 24 Temmuz 2025'te 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131 ve EPS tahminlerini 0,05 $ a\u015farak beklenen 0,62 $'a kar\u015f\u0131l\u0131k 0,67 $ ger\u00e7ek EPS bildirdi.<\/p> <h3><strong>Kazan\u00e7 Raporlar\u0131 EW Hissesini Genellikle Nas\u0131l Hareket Ettirir:<\/strong><\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>24 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>76,84 $<\/td><td>%5,60 art\u0131\u015f (ertesi g\u00fcn rallisi)<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>~70 $<\/td><td>%4,15 ayl\u0131k kazan\u00e7<\/td><\/tr> <tr><td>Ocak 2025<\/td><td>Y\u0131ll\u0131k Rehberlik<\/td><td>~72 $<\/td><td>%2,13 d\u00fc\u015f\u00fc\u015f (temkinli g\u00f6r\u00fcn\u00fcm)<\/td><\/tr> <tr><td>Ekim 2024<\/td><td>3. \u00c7eyrek 2024<\/td><td>~68 $<\/td><td>%3,5 beklentileri a\u015fma<\/td><\/tr> <tr><td>Temmuz 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>~65 $<\/td><td>%6,2 g\u00fc\u00e7l\u00fc TAVR b\u00fcy\u00fcmesi<\/td><\/tr> <\/tbody> <\/table> <p>Model, \u00f6zellikle TAVR sat\u0131\u015flar\u0131 beklentileri a\u015ft\u0131\u011f\u0131nda kazan\u00e7lar\u0131n olumlu tepkiler yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Temmuz 2025 raporu, klinik ba\u015far\u0131n\u0131n do\u011frudan hissedar de\u011ferine nas\u0131l d\u00f6n\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc g\u00f6steren anl\u0131k %5,6'l\u0131k bir art\u0131\u015f tetikledi.<\/p> <h3><strong>6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-Temmuz 2025)<\/strong><\/h3> <p>Edwards hisseleri bu d\u00f6nemde etkileyici bir <strong>%10,6 getiri<\/strong> sa\u011flad\u0131:<\/p> <ul> <li><strong>\u015eubat<\/strong>: 70,10 $ dip, d\u00fczenleyici belirsizlikle m\u00fccadele<\/li> <li><strong>Mart<\/strong>: %1,20 toparlanma, erken TAVR deneme verileri ortaya \u00e7\u0131kt\u0131<\/li> <li><strong>Nisan<\/strong>: %4,15 art\u0131\u015f - en g\u00fc\u00e7l\u00fc ay, 76,60 $ zirve<\/li> <li><strong>May\u0131s<\/strong>: %3,62 y\u00fckseli\u015f, bo\u011fa momentumu devam etti<\/li> <li><strong>Haziran<\/strong>: Dura\u011fan performans (-%0,01), piyasa kazan\u00e7lar\u0131 sindirdi<\/li> <li><strong>Temmuz<\/strong>: %2,89 art\u0131\u015f, yeni 52 haftal\u0131k zirve 83,00 $<\/li> <\/ul> <p>Bu y\u00fckseli\u015f e\u011filimi \u015fu fakt\u00f6rlerle desteklendi:<\/p> <ul> <li><strong>Klinik benimseme<\/strong>: Erken TAVR deneme verileri doktorlar\u0131n ilgisini yeniledi<\/li> <li><strong>Mali performans<\/strong>: 2. \u00e7eyrek sat\u0131\u015flar\u0131 1,53 milyar $, y\u0131ll\u0131k %10,6 art\u0131\u015f<\/li> <li><strong>Rehberlik art\u0131\u015f\u0131<\/strong>: \u015eirket 2025 sat\u0131\u015f b\u00fcy\u00fcme tahminini %9-10'a y\u00fckseltti<\/li> <\/ul> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 95-105 $ aral\u0131\u011f\u0131 (g\u00fc\u00e7l\u00fc tatil \u00e7eyre\u011fi + devam eden TAVR benimsemesi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026 Projeksiyonu<\/strong>: Analist konsens\u00fcs\u00fcne g\u00f6re 88-101 $ aras\u0131 (<a href=\"https:\/\/stockscan.io\/stocks\/EW\/forecast\">28 analist<\/a> ortalama hedef 88,43 $)<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 28-36 $ aral\u0131\u011f\u0131 (baz\u0131 modeller rekabet nedeniyle s\u0131k\u0131\u015fma \u00f6ng\u00f6r\u00fcyor)<\/li> <li><strong>2030 Vizyonu<\/strong>: 91-111 $ (inovasyon ba\u015far\u0131s\u0131na ba\u011fl\u0131 farkl\u0131 tahminler)<\/li> <\/ul> <p>Uzun vadeli tahminlerdeki geni\u015f aral\u0131k, t\u0131bbi cihaz inovasyonunun ikili do\u011fas\u0131n\u0131 yans\u0131t\u0131yor - ya \u00e7\u0131\u011f\u0131r a\u00e7an ba\u015far\u0131 ya da rekabet\u00e7i yer de\u011fi\u015ftirme. Ancak Edwards'\u0131n mevcut momentumu ve 3 milyar $ nakit rezervi \u00f6nemli bir a\u015fa\u011f\u0131 y\u00f6n korumas\u0131 sa\u011fl\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/h3> <ul> <li><strong>D\u00fczenleyici engeller<\/strong>: <a href=\"https:\/\/www.gurufocus.com\/news\/2835664\/decoding-edwards-lifesciences-corp-ew-a-strategic-swot-insight\">Patent davalar\u0131<\/a> ve de\u011fi\u015fen geri \u00f6deme politikalar\u0131<\/li> <li><strong>Artan rekabet<\/strong>: Medtronic ve Abbott, TAVR alternatiflerine milyarlarca dolar yat\u0131r\u0131yor<\/li> <li><strong>Piyasa volatilitesi<\/strong>: 1,08 beta, genel piyasadan %8 daha fazla dalgalanma anlam\u0131na gelir<\/li> <li><strong>De\u011ferleme endi\u015feleri<\/strong>: 31,63 y\u00fcksek EV\/EBIT oran\u0131, primli fiyatlamay\u0131 g\u00f6sterir<\/li> <\/ul> <h3><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/h3> <ul> <li><strong>Kazan\u00e7 s\u00fcrprizleri<\/strong>: 2. \u00e7eyrek EPS 0,67 $, beklenen 0,62 $<\/li> <li><strong>Rehberlik art\u0131r\u0131ld\u0131<\/strong>: Sat\u0131\u015f b\u00fcy\u00fcme tahmini %9-10'a y\u00fckseltildi<\/li> <li><strong>Piyasa liderli\u011fi<\/strong>: 10 milyar $ \u00fczeri TAVR pazar\u0131nda bask\u0131n konum<\/li> <li><strong>\u0130novasyon hatt\u0131<\/strong>: Sat\u0131\u015flar\u0131n %18'i oran\u0131nda g\u00fc\u00e7l\u00fc Ar-Ge yat\u0131r\u0131m\u0131<\/li> <li><strong>Mali g\u00fc\u00e7<\/strong>: Stratejik hamleler i\u00e7in 3 milyar $ nakit rezerv<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 sa\u011fl\u0131k hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>D\u00fc\u015f\u00fc\u015f\u00fc bekleyin<\/strong>: Ekim kazan\u00e7lar\u0131, sonu\u00e7lar hayal k\u0131r\u0131kl\u0131\u011f\u0131 yarat\u0131rsa daha iyi giri\u015f sa\u011flayabilir<\/li> <li><strong>Dolar-maliyet ortalamas\u0131 yap\u0131n<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine sabit miktarlarda ayl\u0131k yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Uyar\u0131lar kurun<\/strong>: EW'yi \u00f6nemli klinik deneme duyurular\u0131 \u00e7evresinde izleyin<\/li> <li><strong>Esprili ger\u00e7eklik kontrol\u00fc<\/strong>: \"T\u0131bbi hisselerle i\u015flem yapmak kalp ameliyat\u0131 gibidir - sabit eller dramatik hareketlerden her zaman daha iyidir\"<\/li> <\/ol> <h2>\u2705 Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Arac\u0131 kurum platformu se\u00e7in<\/td><td>NYSE eri\u015fimi ve d\u00fc\u015f\u00fck komisyon yap\u0131s\u0131n\u0131 garanti edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Risk alabilece\u011finiz miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"EW\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>75-78 $ aral\u0131\u011f\u0131nda limit emir \u00f6nerilir<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Sat\u0131n alma \u00f6ncesi t\u00fcm \u00fccretleri kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Kazan\u00e7 duyurular\u0131 i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>7<\/td><td>Vergi etkilerini de\u011ferlendirin<\/td><td>Olumlu sermaye kazanc\u0131 muamelesi i\u00e7in 1 y\u0131ldan fazla tutun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Edwards Lifesciences hissesiyle stratejileri test etmek i\u00e7in benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - t\u0131bbi sekt\u00f6r volatilitesiyle pratik yapmak i\u00e7in ideal<\/li> <li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> - tek belge y\u00fcklemesi ile hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> - kripto paralardan geleneksel banka transferlerine kadar<\/li> <li><strong>Par\u00e7al\u0131 hisse al\u0131m\u0131 m\u00fcmk\u00fcn<\/strong> - EW'nin tam fiyat\u0131n\u0131 \u00f6demeden k\u0131smi hisse sat\u0131n al\u0131n<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, sa\u011fl\u0131k hisselerinin klinik deneme sonu\u00e7lar\u0131 ve FDA duyurular\u0131 \u00e7evresinde nas\u0131l davrand\u0131\u011f\u0131n\u0131 \u00f6\u011frenmek i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Edwards Lifesciences: Kalp \u0130novasyon Lideri<\/h2> <p>Edwards, SAPIEN transkateter aortik valf gibi devrim niteli\u011findeki teknolojilerle yap\u0131sal kalp cihazlar\u0131 pazar\u0131nda hakimdir. \u015eirketin <a href=\"https:\/\/ir.edwards.com\/news\/news-details\/2025\/Edwards-Lifesciences-Reports-Second-Quarter-Results\/default.aspx\">2025 2. \u00e7eyrek sonu\u00e7lar\u0131<\/a> ola\u011fan\u00fcst\u00fc g\u00fcc\u00fc g\u00f6steriyor: 1,53 milyar $ sat\u0131\u015f, %10,6 b\u00fcy\u00fcme ve sadece TAVR \u00fcr\u00fcnleri 1,1 milyar $ gelir sa\u011flad\u0131.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Edwards, bu y\u0131l 800 milyon $ \u00fczeri hisse geri al\u0131m program\u0131 a\u00e7\u0131klarken, Ar-Ge yat\u0131r\u0131mlar\u0131n\u0131 sat\u0131\u015flar\u0131n %18'ine \u00e7\u0131kard\u0131 - bu, hissedar getirileri ve inovasyon taahh\u00fcd\u00fcn\u00fcn nadir bir birle\u015fimi olup ola\u011fan\u00fcst\u00fc mali disiplin g\u00f6sterir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Edwards Lifesciences Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla Edwards Lifesciences Corporation (EW), NYSE&#8217;de <strong>78,93 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Bu, yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici bir an\u0131 temsil ediyor &#8211; hisse senedi, Temmuz 2025&#8217;te ula\u015f\u0131lan 52 haftal\u0131k en y\u00fcksek seviye olan 83,00 $&#8217;\u0131n sadece %5 alt\u0131nda i\u015flem g\u00f6r\u00fcyor ve g\u00fc\u00e7l\u00fc temellerini koruyor.<\/p>\n<p><strong>Takviminize Not Edin: 23 Ekim 2025<\/strong> &#8211; Edwards, piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketlerine neden olur. \u015eirket, 24 Temmuz 2025&#8217;te 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131 ve EPS tahminlerini 0,05 $ a\u015farak beklenen 0,62 $&#8217;a kar\u015f\u0131l\u0131k 0,67 $ ger\u00e7ek EPS bildirdi.<\/p>\n<h3><strong>Kazan\u00e7 Raporlar\u0131 EW Hissesini Genellikle Nas\u0131l Hareket Ettirir:<\/strong><\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>24 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>76,84 $<\/td>\n<td>%5,60 art\u0131\u015f (ertesi g\u00fcn rallisi)<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>~70 $<\/td>\n<td>%4,15 ayl\u0131k kazan\u00e7<\/td>\n<\/tr>\n<tr>\n<td>Ocak 2025<\/td>\n<td>Y\u0131ll\u0131k Rehberlik<\/td>\n<td>~72 $<\/td>\n<td>%2,13 d\u00fc\u015f\u00fc\u015f (temkinli g\u00f6r\u00fcn\u00fcm)<\/td>\n<\/tr>\n<tr>\n<td>Ekim 2024<\/td>\n<td>3. \u00c7eyrek 2024<\/td>\n<td>~68 $<\/td>\n<td>%3,5 beklentileri a\u015fma<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>~65 $<\/td>\n<td>%6,2 g\u00fc\u00e7l\u00fc TAVR b\u00fcy\u00fcmesi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Model, \u00f6zellikle TAVR sat\u0131\u015flar\u0131 beklentileri a\u015ft\u0131\u011f\u0131nda kazan\u00e7lar\u0131n olumlu tepkiler yaratt\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Temmuz 2025 raporu, klinik ba\u015far\u0131n\u0131n do\u011frudan hissedar de\u011ferine nas\u0131l d\u00f6n\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc g\u00f6steren anl\u0131k %5,6&#8217;l\u0131k bir art\u0131\u015f tetikledi.<\/p>\n<h3><strong>6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-Temmuz 2025)<\/strong><\/h3>\n<p>Edwards hisseleri bu d\u00f6nemde etkileyici bir <strong>%10,6 getiri<\/strong> sa\u011flad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat<\/strong>: 70,10 $ dip, d\u00fczenleyici belirsizlikle m\u00fccadele<\/li>\n<li><strong>Mart<\/strong>: %1,20 toparlanma, erken TAVR deneme verileri ortaya \u00e7\u0131kt\u0131<\/li>\n<li><strong>Nisan<\/strong>: %4,15 art\u0131\u015f &#8211; en g\u00fc\u00e7l\u00fc ay, 76,60 $ zirve<\/li>\n<li><strong>May\u0131s<\/strong>: %3,62 y\u00fckseli\u015f, bo\u011fa momentumu devam etti<\/li>\n<li><strong>Haziran<\/strong>: Dura\u011fan performans (-%0,01), piyasa kazan\u00e7lar\u0131 sindirdi<\/li>\n<li><strong>Temmuz<\/strong>: %2,89 art\u0131\u015f, yeni 52 haftal\u0131k zirve 83,00 $<\/li>\n<\/ul>\n<p>Bu y\u00fckseli\u015f e\u011filimi \u015fu fakt\u00f6rlerle desteklendi:<\/p>\n<ul>\n<li><strong>Klinik benimseme<\/strong>: Erken TAVR deneme verileri doktorlar\u0131n ilgisini yeniledi<\/li>\n<li><strong>Mali performans<\/strong>: 2. \u00e7eyrek sat\u0131\u015flar\u0131 1,53 milyar $, y\u0131ll\u0131k %10,6 art\u0131\u015f<\/li>\n<li><strong>Rehberlik art\u0131\u015f\u0131<\/strong>: \u015eirket 2025 sat\u0131\u015f b\u00fcy\u00fcme tahminini %9-10&#8217;a y\u00fckseltti<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 95-105 $ aral\u0131\u011f\u0131 (g\u00fc\u00e7l\u00fc tatil \u00e7eyre\u011fi + devam eden TAVR benimsemesi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: Analist konsens\u00fcs\u00fcne g\u00f6re 88-101 $ aras\u0131 (<a href=\"https:\/\/stockscan.io\/stocks\/EW\/forecast\">28 analist<\/a> ortalama hedef 88,43 $)<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 28-36 $ aral\u0131\u011f\u0131 (baz\u0131 modeller rekabet nedeniyle s\u0131k\u0131\u015fma \u00f6ng\u00f6r\u00fcyor)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 91-111 $ (inovasyon ba\u015far\u0131s\u0131na ba\u011fl\u0131 farkl\u0131 tahminler)<\/li>\n<\/ul>\n<p>Uzun vadeli tahminlerdeki geni\u015f aral\u0131k, t\u0131bbi cihaz inovasyonunun ikili do\u011fas\u0131n\u0131 yans\u0131t\u0131yor &#8211; ya \u00e7\u0131\u011f\u0131r a\u00e7an ba\u015far\u0131 ya da rekabet\u00e7i yer de\u011fi\u015ftirme. Ancak Edwards&#8217;\u0131n mevcut momentumu ve 3 milyar $ nakit rezervi \u00f6nemli bir a\u015fa\u011f\u0131 y\u00f6n korumas\u0131 sa\u011fl\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/h3>\n<ul>\n<li><strong>D\u00fczenleyici engeller<\/strong>: <a href=\"https:\/\/www.gurufocus.com\/news\/2835664\/decoding-edwards-lifesciences-corp-ew-a-strategic-swot-insight\">Patent davalar\u0131<\/a> ve de\u011fi\u015fen geri \u00f6deme politikalar\u0131<\/li>\n<li><strong>Artan rekabet<\/strong>: Medtronic ve Abbott, TAVR alternatiflerine milyarlarca dolar yat\u0131r\u0131yor<\/li>\n<li><strong>Piyasa volatilitesi<\/strong>: 1,08 beta, genel piyasadan %8 daha fazla dalgalanma anlam\u0131na gelir<\/li>\n<li><strong>De\u011ferleme endi\u015feleri<\/strong>: 31,63 y\u00fcksek EV\/EBIT oran\u0131, primli fiyatlamay\u0131 g\u00f6sterir<\/li>\n<\/ul>\n<h3><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/h3>\n<ul>\n<li><strong>Kazan\u00e7 s\u00fcrprizleri<\/strong>: 2. \u00e7eyrek EPS 0,67 $, beklenen 0,62 $<\/li>\n<li><strong>Rehberlik art\u0131r\u0131ld\u0131<\/strong>: Sat\u0131\u015f b\u00fcy\u00fcme tahmini %9-10&#8217;a y\u00fckseltildi<\/li>\n<li><strong>Piyasa liderli\u011fi<\/strong>: 10 milyar $ \u00fczeri TAVR pazar\u0131nda bask\u0131n konum<\/li>\n<li><strong>\u0130novasyon hatt\u0131<\/strong>: Sat\u0131\u015flar\u0131n %18&#8217;i oran\u0131nda g\u00fc\u00e7l\u00fc Ar-Ge yat\u0131r\u0131m\u0131<\/li>\n<li><strong>Mali g\u00fc\u00e7<\/strong>: Stratejik hamleler i\u00e7in 3 milyar $ nakit rezerv<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 sa\u011fl\u0131k hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>D\u00fc\u015f\u00fc\u015f\u00fc bekleyin<\/strong>: Ekim kazan\u00e7lar\u0131, sonu\u00e7lar hayal k\u0131r\u0131kl\u0131\u011f\u0131 yarat\u0131rsa daha iyi giri\u015f sa\u011flayabilir<\/li>\n<li><strong>Dolar-maliyet ortalamas\u0131 yap\u0131n<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine sabit miktarlarda ayl\u0131k yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Uyar\u0131lar kurun<\/strong>: EW&#8217;yi \u00f6nemli klinik deneme duyurular\u0131 \u00e7evresinde izleyin<\/li>\n<li><strong>Esprili ger\u00e7eklik kontrol\u00fc<\/strong>: &#8220;T\u0131bbi hisselerle i\u015flem yapmak kalp ameliyat\u0131 gibidir &#8211; sabit eller dramatik hareketlerden her zaman daha iyidir&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Arac\u0131 kurum platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve d\u00fc\u015f\u00fck komisyon yap\u0131s\u0131n\u0131 garanti edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Risk alabilece\u011finiz miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;EW&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>75-78 $ aral\u0131\u011f\u0131nda limit emir \u00f6nerilir<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Sat\u0131n alma \u00f6ncesi t\u00fcm \u00fccretleri kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Kazan\u00e7 duyurular\u0131 i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Vergi etkilerini de\u011ferlendirin<\/td>\n<td>Olumlu sermaye kazanc\u0131 muamelesi i\u00e7in 1 y\u0131ldan fazla tutun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Edwards Lifesciences hissesiyle stratejileri test etmek i\u00e7in benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; t\u0131bbi sekt\u00f6r volatilitesiyle pratik yapmak i\u00e7in ideal<\/li>\n<li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> &#8211; tek belge y\u00fcklemesi ile hemen i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; kripto paralardan geleneksel banka transferlerine kadar<\/li>\n<li><strong>Par\u00e7al\u0131 hisse al\u0131m\u0131 m\u00fcmk\u00fcn<\/strong> &#8211; EW&#8217;nin tam fiyat\u0131n\u0131 \u00f6demeden k\u0131smi hisse sat\u0131n al\u0131n<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, sa\u011fl\u0131k hisselerinin klinik deneme sonu\u00e7lar\u0131 ve FDA duyurular\u0131 \u00e7evresinde nas\u0131l davrand\u0131\u011f\u0131n\u0131 \u00f6\u011frenmek i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Edwards Lifesciences: Kalp \u0130novasyon Lideri<\/h2>\n<p>Edwards, SAPIEN transkateter aortik valf gibi devrim niteli\u011findeki teknolojilerle yap\u0131sal kalp cihazlar\u0131 pazar\u0131nda hakimdir. \u015eirketin <a href=\"https:\/\/ir.edwards.com\/news\/news-details\/2025\/Edwards-Lifesciences-Reports-Second-Quarter-Results\/default.aspx\">2025 2. \u00e7eyrek sonu\u00e7lar\u0131<\/a> ola\u011fan\u00fcst\u00fc g\u00fcc\u00fc g\u00f6steriyor: 1,53 milyar $ sat\u0131\u015f, %10,6 b\u00fcy\u00fcme ve sadece TAVR \u00fcr\u00fcnleri 1,1 milyar $ gelir sa\u011flad\u0131.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Edwards, bu y\u0131l 800 milyon $ \u00fczeri hisse geri al\u0131m program\u0131 a\u00e7\u0131klarken, Ar-Ge yat\u0131r\u0131mlar\u0131n\u0131 sat\u0131\u015flar\u0131n %18&#8217;ine \u00e7\u0131kard\u0131 &#8211; bu, hissedar getirileri ve inovasyon taahh\u00fcd\u00fcn\u00fcn nadir bir birle\u015fimi olup ola\u011fan\u00fcst\u00fc mali disiplin g\u00f6sterir.<\/p>\n"},"faq":[{"question":"Edwards Lifesciences hisseleri nereden al\u0131nabilir?","answer":"Edwards Lifesciences hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve \u00e7o\u011fu b\u00fcy\u00fck arac\u0131 kurum ve \u00e7evrimi\u00e7i yat\u0131r\u0131m platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Edwards Lifesciences hissesi almak i\u00e7in minimum yat\u0131r\u0131m miktar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m miktar\u0131 se\u00e7ti\u011finiz arac\u0131 kuruma ba\u011fl\u0131d\u0131r, ancak Pocket Option gibi platformlarda 5 $ gibi d\u00fc\u015f\u00fck depozito ile ba\u015flayabilirsiniz."},{"question":"Edwards Lifesciences hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda d\u00fczenleyici engeller, artan rekabet, piyasa volatilitesi ve y\u00fcksek de\u011ferleme yer almaktad\u0131r."},{"question":"Edwards Lifesciences hisseleri i\u00e7in 2025 fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat tahmini 95-105 $ aral\u0131\u011f\u0131nda olup, g\u00fc\u00e7l\u00fc bir \"G\u00dc\u00c7L\u00dc AL\" sinyali vermektedir."},{"question":"Yeni ba\u015flayanlar Edwards Lifesciences hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, piyasa d\u00fc\u015f\u00fc\u015flerini bekleyerek, dolar-maliyet ortalamas\u0131 yaparak ve fiyat uyar\u0131lar\u0131 kurarak yat\u0131r\u0131m yapmalar\u0131 \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Edwards Lifesciences hisseleri nereden al\u0131nabilir?","answer":"Edwards Lifesciences hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve \u00e7o\u011fu b\u00fcy\u00fck arac\u0131 kurum ve \u00e7evrimi\u00e7i yat\u0131r\u0131m platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Edwards Lifesciences hissesi almak i\u00e7in minimum yat\u0131r\u0131m miktar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m miktar\u0131 se\u00e7ti\u011finiz arac\u0131 kuruma ba\u011fl\u0131d\u0131r, ancak Pocket Option gibi platformlarda 5 $ gibi d\u00fc\u015f\u00fck depozito ile ba\u015flayabilirsiniz."},{"question":"Edwards Lifesciences hisselerinin riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda d\u00fczenleyici engeller, artan rekabet, piyasa volatilitesi ve y\u00fcksek de\u011ferleme yer almaktad\u0131r."},{"question":"Edwards Lifesciences hisseleri i\u00e7in 2025 fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in fiyat tahmini 95-105 $ aral\u0131\u011f\u0131nda olup, g\u00fc\u00e7l\u00fc bir \"G\u00dc\u00c7L\u00dc AL\" sinyali vermektedir."},{"question":"Yeni ba\u015flayanlar Edwards Lifesciences hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, piyasa d\u00fc\u015f\u00fc\u015flerini bekleyerek, dolar-maliyet ortalamas\u0131 yaparak ve fiyat uyar\u0131lar\u0131 kurarak yat\u0131r\u0131m yapmalar\u0131 \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T18:21:50+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T18:21:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/\",\"name\":\"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-20T18:21:50+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T18:21:50+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T18:21:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/","name":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r - Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-20T18:21:50+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Edwards Lifesciences Corporation (EW) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Edwards Lifesciences Corporation (EW) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":342558,"slug":"how-to-buy-edwards-lifesciences-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Edwards Lifesciences Corporation (EW) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Edwards Lifesciences Corporation (EW)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/"},"pt_AA":{"locale":"pt_AA","id":342555,"slug":"how-to-buy-edwards-lifesciences-corporation","post_title":"Como comprar a\u00e7\u00f5es da Edwards Lifesciences Corporation (EW) - Investimento em a\u00e7\u00f5es da Edwards Lifesciences Corporation (EW)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-edwards-lifesciences-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=342549"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342549\/revisions"}],"predecessor-version":[{"id":342552,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342549\/revisions\/342552"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=342549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=342549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=342549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}